WO2004012574A3 - Negative selections assays, and compositions thereof - Google Patents
Negative selections assays, and compositions thereof Download PDFInfo
- Publication number
- WO2004012574A3 WO2004012574A3 PCT/US2003/022241 US0322241W WO2004012574A3 WO 2004012574 A3 WO2004012574 A3 WO 2004012574A3 US 0322241 W US0322241 W US 0322241W WO 2004012574 A3 WO2004012574 A3 WO 2004012574A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- assays
- compositions
- negative selections
- cytotoxicity
- selections
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Abstract
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2003256572A AU2003256572A1 (en) | 2002-07-16 | 2003-07-16 | Negative selections assays, and compositions thereof |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US39617102P | 2002-07-16 | 2002-07-16 | |
US60/396,171 | 2002-07-16 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2004012574A2 WO2004012574A2 (en) | 2004-02-12 |
WO2004012574A3 true WO2004012574A3 (en) | 2005-02-03 |
Family
ID=31495712
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2003/022241 WO2004012574A2 (en) | 2002-07-16 | 2003-07-16 | Negative selections assays, and compositions thereof |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2003256572A1 (en) |
WO (1) | WO2004012574A2 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20130035255A1 (en) | 2010-03-26 | 2013-02-07 | Integratech Proteomics, Llc | Controlled release hybrid systems |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6368598B1 (en) * | 1996-09-16 | 2002-04-09 | Jcrt Radiation Oncology Support Services, Inc. | Drug complex for treatment of metastatic prostate cancer |
-
2003
- 2003-07-16 AU AU2003256572A patent/AU2003256572A1/en not_active Abandoned
- 2003-07-16 WO PCT/US2003/022241 patent/WO2004012574A2/en not_active Application Discontinuation
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6368598B1 (en) * | 1996-09-16 | 2002-04-09 | Jcrt Radiation Oncology Support Services, Inc. | Drug complex for treatment of metastatic prostate cancer |
Non-Patent Citations (2)
Title |
---|
ADRA ET AL.: "RhoGDIgama : A GDP-dissociation inhibitor for Rho proteins with preferentionl expression in brain and pancreas", PROC. NATL. ACAD. SCI. USA, vol. 94, no. 9, 29 April 1997 (1997-04-29), USA, pages 4279 - 4284, XP002903187 * |
DATABASE GENBANK [online] 17 April 2001 (2001-04-17), WAN ET AL., XP002903186, accession no. NCBI Database accession no. (AF250306) * |
Also Published As
Publication number | Publication date |
---|---|
AU2003256572A1 (en) | 2004-02-23 |
WO2004012574A2 (en) | 2004-02-12 |
AU2003256572A8 (en) | 2004-02-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RS50660B (en) | Dihydrotetrabenazines and pharmaceutical compositions containing them | |
WO2005005679A3 (en) | Super-hydrophobic surfaces, methods of their construction and uses therefor | |
ZA200305993B (en) | Herbicidal compositions. | |
HUP0302226A3 (en) | Substituted pyrrolopyridinone dervatives useful as phosphodiesterse inhibitors, their intermediates and pharmaceutical compositions containing the compounds | |
EP1691842A4 (en) | Treatment of proliferative diseases using an antisense iap oligomer and chemotherapeutic agent | |
WO2007133290A8 (en) | Anti-ox40l antibodies and methods using same | |
WO2005047898A3 (en) | Methods and compositions for identifying therapeutic compounds | |
WO2003070701A3 (en) | Syntheses of quinazolinones | |
WO2006088803A3 (en) | Polypeptides from staphylococcus aureus and methods of use | |
MY143677A (en) | Amide prodrug of gemcitabine, compositions and use thereof | |
AP2005003195A0 (en) | Herbicidal compositions. | |
WO2003057145A3 (en) | SUBSTITUTED 4,9-DIHYDROCYCLOPENTA[imn]PHENANTHRIDINE-5-ONES DERIVATIVES THEREOF AND THEIR USES | |
HK1049796B (en) | Mixture comprising an inhibitor or suppressor of a gene and a molecule binding to an expression product of that gene | |
AU8738401A (en) | Novel kallikrein gene | |
ZA200604874B (en) | Pharmaceutical compositions | |
WO2006078998A3 (en) | Methods and compositions for decreasing saliva production | |
WO2007022321A3 (en) | Substituted indoles and use thereof | |
WO2002064574A3 (en) | Pyridoarylphenyl oxazolidinone antibacterials, and related compositions and methods | |
WO2001061346A3 (en) | Methods for identifying agents causing a lethal phenotype | |
WO2006027345A3 (en) | Novel 3-thia-10-aza-phenanthrene derivatives | |
WO2004012574A3 (en) | Negative selections assays, and compositions thereof | |
WO2004022578A3 (en) | Methods, compositions and libraries pertaining pna dimer and pna oligomer synthesis | |
WO2004026892A3 (en) | Fragmentation of dna | |
WO2006027344A3 (en) | 3-oxa-10-aza-phenanthrenes as pde4 or pde3/4 inhibitors | |
WO2005075457A8 (en) | Phthalazinone-derivatives as pde4 inhibitors |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
32PN | Ep: public notification in the ep bulletin as address of the adressee cannot be established | ||
32PN | Ep: public notification in the ep bulletin as address of the adressee cannot be established |
Free format text: NOTING OF LOSS OF RIGHTS PURSUANT TO RULE 69(1) EPC (EPO FORM 1205A DATED 08.06.2005) |
|
NENP | Non-entry into the national phase |
Ref country code: JP |
|
WWW | Wipo information: withdrawn in national office |
Country of ref document: JP |